Piramal Pharma Ltd.

BSE: 543635 | NSE: PPLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE0DK501011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Piramal Pharma Piramal Pharma Ltd. | BSE 174.45 -5.50 (-3.06%) | NSE 174.51 -5.34 (-2.97%) | Trade | Add

BSE Live

Dec 08, 13:25

174.45 -5.50 (-3.06%)

Volume

AVERAGE VOLUME

5-Day

202,141

10-Day

181,871

30-Day

347,882

119,874

Prev. Close

179.95
Open Price

180.05

Bid Price (Qty.)
174.35 (381)
Offer Price (Qty.)
174.55 (268)

NSE Live

Dec 08, 13:25

174.51 -5.34 (-2.97%)

Volume

AVERAGE VOLUME

5-Day

2,515,762

10-Day

2,308,888

30-Day

5,167,622

1,753,552

Prev. Close

179.85
Open Price

180.30

Bid Price (Qty.)
174.43 (95)
Offer Price (Qty.)
174.46 (1)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Piramal Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	13 mths
INCOME
Revenue From Operations [Gross]	5,202.56	4,325.31	3,349.59	2,977.57	2,899.75
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	5,202.56	4,325.31	3,349.59	2,977.57	2,899.75
Total Operating Revenues	5,285.71	4,390.11	3,443.22	3,094.95	2,938.81
Other Income	207.35	202.06	341.07	223.59	197.97
Total Revenue	5,493.06	4,592.17	3,784.29	3,318.54	3,136.78
EXPENSES
Cost Of Materials Consumed	1,596.93	1,545.55	1,166.48	1,003.68	986.70
Purchase Of Stock-In Trade	733.60	624.91	548.69	509.70	183.21
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-84.57	-61.62	53.31	-30.17	57.86
Employee Benefit Expenses	736.19	613.93	548.50	425.30	395.15
Finance Costs	114.56	107.10	115.87	53.55	4.71
Depreciation And Amortisation Expenses	222.09	205.26	192.08	130.64	143.64
Other Expenses	1,263.12	1,049.42	1,028.71	789.14	696.96
Total Expenses	4,581.92	4,084.55	3,653.64	2,881.84	2,468.23
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	911.14	507.62	130.65	436.70	668.55
Exceptional Items	0.00	0.00	-6.96	-12.47	18.23
Profit/Loss Before Tax	911.14	507.62	123.69	424.23	686.78
Tax Expenses-Continued Operations
Current Tax	199.44	112.48	38.77	96.34	104.98
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.30	3.92	15.42	-15.16	10.30
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	219.74	116.40	54.19	81.18	115.28
Profit/Loss After Tax And Before ExtraOrdinary Items	691.40	391.22	69.50	343.05	571.50
Profit/Loss From Continuing Operations	691.40	391.22	69.50	343.05	571.50
Profit/Loss For The Period	691.40	391.22	69.50	343.05	571.50
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	5.22	3.05	0.58	2.91	9.11
Diluted EPS (Rs.)	5.20	3.05	0.58	2.91	9.11
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	14.47	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	1.00	1.00	0.00	0.00	0.00